Melanoma Drug Succeeds in Late-Stage Trial

Wednesday, March 20, 2013 - 15:20 in Health & Medicine

Amgen, which is developing the cancer drug to treat advanced melanoma, said it was too early to say whether the drug improved survival.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net